Synaptic transmission blockade increases plasminogen activator activity in mouse skeletal muscle poisoned with botulinum toxin type A.
Experimental denervation, either by nerve crush or axotomy, leads to a dramatic increase in muscle plasminogen activator (PA) activity, suggesting a regulation of muscle PA levels by some neural influence (Festoff et al., 1986, J. Cell Biol., 103:1415-1421; Hantaï et al., 1990, Proc. Natl. Acad. Sci. U.S.A., 87:2926-2930). The Botulinum toxin (BoTx) type A is known to selectively interrupt the release of acetylcholine without structurally altering synaptic morphology. In the present study we have used acute BoTx poisoning of hind limb muscles to further explore the neural regulation of muscle PA activities directly after poisoning and during the process of collateral reinnervation. Electromyographic recording and study of ultraterminal sprouting after zinc iodideosmium and silver-cholinesterase staining were used to monitor "denervation" and reinnervation. Muscle choline acetyltransferase activity did not decrease, as is observed after experimental denervation, but in contrast increased and, therefore, reflected the functional integrity of intramuscular nerve endings. Within 2 days of BoTx poisoning, muscle urokinase-PA, and to a lesser extent, tissue-PA activities, rose in muscle extracts as shown by an amidolytic assay and fibrin zymography. When reinnervation occurred, muscle urokinase-PA activity decreased but did not return to baseline levels within the 80 days of our study. These results suggest that cholinergic transmission-regulated events determine activity of muscle PAs and that PAs likely have a role in neuromuscular formation and plasticity.
Tian
W H
WH
Développement, Pathologie, Régénération du Système Neuromusculaire, INSERM U.153, CNRS ERS 64, Paris, France.
Festoff
B W
BW
Blot
S
S
Diaz
J
J
Hantaï
D
D
D000595:Amino Acid Sequence; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D001905:Botulinum Toxins / Q000633:toxicity*; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004576:Electromyography; D005260:Female; D005337:Fibrin / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008969:Molecular Sequence Data; D009045:Motor Endplate / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D009046:Motor Neurons / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D009121:Muscle Denervation; D018482:Muscle, Skeletal / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009473:Neuronal Plasticity / Q000502:physiology; D010960:Plasminogen Activators / Q000096:biosynthesis*; D013569:Synapses / Q000201:enzymology / Q000502:physiology*; D009435:Synaptic Transmission / Q000502:physiology*
D005337:Fibrin; D002795:Choline O-Acetyltransferase; D010960:Plasminogen Activators; D001905:Botulinum Toxins